Literature DB >> 16200195

IKK/NF-kappaB signaling: balancing life and death--a new approach to cancer therapy.

Jun-Li Luo1, Hideaki Kamata, Michael Karin.   

Abstract

IkappaB kinase/NF-kappaB (IKK/NF-kappaB) signaling pathways play critical roles in a variety of physiological and pathological processes. One function of NF-kappaB is promotion of cell survival through induction of target genes, whose products inhibit components of the apoptotic machinery in normal and cancerous cells. NF-kappaB can also prevent programmed necrosis by inducing genes encoding antioxidant proteins. Regardless of mechanism, many cancer cells, of either epithelial or hematopoietic origin, use NF-kappaB to achieve resistance to anticancer drugs, radiation, and death cytokines. Hence, inhibition of IKK-driven NF-kappaB activation offers a strategy for treatment of different malignancies and can convert inflammation-induced tumor growth to inflammation-induced tumor regression.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16200195      PMCID: PMC1236696          DOI: 10.1172/JCI26322

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  119 in total

1.  Modulation of transcription factor NF-kappa B binding activity by oxidation-reduction in vitro.

Authors:  M B Toledano; W J Leonard
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-15       Impact factor: 11.205

2.  Initiation of liver growth by tumor necrosis factor: deficient liver regeneration in mice lacking type I tumor necrosis factor receptor.

Authors:  Y Yamada; I Kirillova; J J Peschon; N Fausto
Journal:  Proc Natl Acad Sci U S A       Date:  1997-02-18       Impact factor: 11.205

Review 3.  Cell death: the significance of apoptosis.

Authors:  A H Wyllie; J F Kerr; A R Currie
Journal:  Int Rev Cytol       Date:  1980

4.  Manganous superoxide dismutase is essential for cellular resistance to cytotoxicity of tumor necrosis factor.

Authors:  G H Wong; J H Elwell; L W Oberley; D V Goeddel
Journal:  Cell       Date:  1989-09-08       Impact factor: 41.582

5.  The regulation of anoikis: MEKK-1 activation requires cleavage by caspases.

Authors:  M H Cardone; G S Salvesen; C Widmann; G Johnson; S M Frisch
Journal:  Cell       Date:  1997-07-25       Impact factor: 41.582

6.  The tumor promoter arsenite stimulates AP-1 activity by inhibiting a JNK phosphatase.

Authors:  M Cavigelli; W W Li; A Lin; B Su; K Yoshioka; M Karin
Journal:  EMBO J       Date:  1996-11-15       Impact factor: 11.598

7.  TGF-beta suppresses tumor progression in colon cancer by inhibition of IL-6 trans-signaling.

Authors:  Christoph Becker; Massimo C Fantini; Christoph Schramm; Hans A Lehr; Stefan Wirtz; Alexei Nikolaev; Jürgen Burg; Susanne Strand; Ralf Kiesslich; Samuel Huber; Hiroaki Ito; Norihiro Nishimoto; Kazuyuki Yoshizaki; Tadamitsu Kishimoto; Peter R Galle; Manfred Blessing; Stefan Rose-John; Markus F Neurath
Journal:  Immunity       Date:  2004-10       Impact factor: 31.745

8.  Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-kappa B.

Authors:  A A Beg; W C Sha; R T Bronson; S Ghosh; D Baltimore
Journal:  Nature       Date:  1995-07-13       Impact factor: 49.962

9.  Pyrrolidine dithiocarbamate, a potent inhibitor of nuclear factor kappa B (NF-kappa B) activation, prevents apoptosis in human promyelocytic leukemia HL-60 cells and thymocytes.

Authors:  R Bessho; K Matsubara; M Kubota; K Kuwakado; H Hirota; Y Wakazono; Y W Lin; A Okuda; M Kawai; R Nishikomori
Journal:  Biochem Pharmacol       Date:  1994-11-16       Impact factor: 5.858

Review 10.  Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics.

Authors:  J F Kerr; A H Wyllie; A R Currie
Journal:  Br J Cancer       Date:  1972-08       Impact factor: 7.640

View more
  280 in total

1.  Inhibitory Effects of JEUD-38, a New Sesquiterpene Lactone from Inula japonica Thunb, on LPS-Induced iNOS Expression in RAW264.7 Cells.

Authors:  Xiaoqing Wang; Sheng-An Tang; Ran Wang; Yuling Qiu; Meihua Jin; Dexin Kong
Journal:  Inflammation       Date:  2015       Impact factor: 4.092

2.  Conditional ablation of Ikkb inhibits melanoma tumor development in mice.

Authors:  Jinming Yang; Ryan Splittgerber; Fiona E Yull; Sara Kantrow; Gregory D Ayers; Michael Karin; Ann Richmond
Journal:  J Clin Invest       Date:  2010-06-07       Impact factor: 14.808

3.  FER tyrosine kinase (FER) overexpression mediates resistance to quinacrine through EGF-dependent activation of NF-kappaB.

Authors:  Canhui Guo; George R Stark
Journal:  Proc Natl Acad Sci U S A       Date:  2011-04-25       Impact factor: 11.205

Review 4.  Adenosine and hypoxia-inducible factor signaling in intestinal injury and recovery.

Authors:  Sean P Colgan; Holger K Eltzschig
Journal:  Annu Rev Physiol       Date:  2011-11-19       Impact factor: 19.318

Review 5.  Inhibiting NF-κB activation by small molecules as a therapeutic strategy.

Authors:  Subash C Gupta; Chitra Sundaram; Simone Reuter; Bharat B Aggarwal
Journal:  Biochim Biophys Acta       Date:  2010-05-21

6.  Blocking IKKα expression inhibits prostate cancer invasiveness.

Authors:  Rubi Mahato; Bin Qin; Kun Cheng
Journal:  Pharm Res       Date:  2010-12-30       Impact factor: 4.200

7.  TLR2 enhances ovarian cancer stem cell self-renewal and promotes tumor repair and recurrence.

Authors:  Ilana Chefetz; Ayesha B Alvero; Jennie C Holmberg; Noah Lebowitz; Vinicius Craveiro; Yang Yang-Hartwich; Gang Yin; Lisa Squillace; Marta Gurrea Soteras; Paulomi Aldo; Gil Mor
Journal:  Cell Cycle       Date:  2013-01-16       Impact factor: 4.534

8.  The radiosensitization effect of parthenolide in prostate cancer cells is mediated by nuclear factor-kappaB inhibition and enhanced by the presence of PTEN.

Authors:  Yulan Sun; Daret K St Clair; Fang Fang; Graham W Warren; Vivek M Rangnekar; Peter A Crooks; William H St Clair
Journal:  Mol Cancer Ther       Date:  2007-09       Impact factor: 6.261

9.  Calcium-dependent regulation of NEMO nuclear export in response to genotoxic stimuli.

Authors:  Craig M Berchtold; Zhao-Hui Wu; Tony T Huang; Shigeki Miyamoto
Journal:  Mol Cell Biol       Date:  2006-10-30       Impact factor: 4.272

10.  Differences and Similarities in TRAIL- and Tumor Necrosis Factor-Mediated Necroptotic Signaling in Cancer Cells.

Authors:  Justyna Sosna; Stephan Philipp; Johaiber Fuchslocher Chico; Carina Saggau; Jürgen Fritsch; Alexandra Föll; Johannes Plenge; Christoph Arenz; Thomas Pinkert; Holger Kalthoff; Anna Trauzold; Ingo Schmitz; Stefan Schütze; Dieter Adam
Journal:  Mol Cell Biol       Date:  2016-09-26       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.